Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases

Published:2021-09-06 Issue:2 Volume:81 Page:289-291
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Cook Claire,Patel Naomi J,D’Silva Kristin M.,Hsu Tiffany Y -T^ORCID,DiIorio Michael,Prisco Lauren,Martin Lily W,Vanni Kathleen,Zaccardelli Alessandra,Todd Derrick,Sparks Jeffrey A^ORCID,Wallace Zachary Scott^ORCID

Funder

Brigham Research Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases

R. Bruce and Joan M. Mickey Research Scholar Fund

National Institutes of Health Ruth L. Kirschstein Institutional National Research Service Award

Rheumatology Research Foundation

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19;Sadoff;N Engl J Med,2021

4. COVID-19 vaccination and antirheumatic therapy;Arnold;Rheumatology,2021

5. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease;D'Silva;Ann Rheum Dis,2021

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study;Vaccines;2024-09-09

2. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study;Rheumatology International;2024-08-13

3. COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab;ACR Open Rheumatology;2024-06-23

4. Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study;International Journal of Rheumatic Diseases;2024-05

5. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across‐sectional study;International Journal of Rheumatic Diseases;2024-04